Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0R3M stock hub

LON/0R3M has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R3Mis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

32.7M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R3M

In the news

Latest news · LON/0R3M

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-140.4

P25 -54.2P50 2.1P75 13.7

ROIC-86.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R3M market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

EUR

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	UK
Employees	14
Employees Change	-1%
Employees Change Percent	-6.67
Enterprise value	EUR 28M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	NL00150002Q7
Last refreshed	2026-05-10
Market cap	EUR 32.7M
Price	EUR 1.28
Price currency	EUR
Sector	Healthcare
Sic	2836
Symbol	lon/0R3M
Website	https://www.vivoryon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.59%
EV Earnings	-3.62x
EV/FCF	-3.79x
FCF yield	-22.54%
P/B ratio	7.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -7.7M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Profit Per Employee	EUR -594,086
ROA	-59.25
Roa5y	-54.8
ROCE	-133.4
ROE	-140.4
Roe5y	-111.6
ROIC	-86.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-24.64%
Cagr1y	-26.79%
Cagr3y	-59.37%
Cagr5y	-38.34%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 6.6M
Cash	EUR 4.9M
Current Assets	EUR 5.6M
Current Liabilities	EUR 724,032
Debt	EUR 94,216
Debt Equity	EUR 0.02
Debt FCF	EUR -0.01
Equity	EUR 4.1M
Interest Coverage	-198
Liabilities	EUR 2.4M
Long Term Assets	EUR 998,940
Long Term Liabilities	EUR 1.7M
Net Cash	EUR 4.8M
Net Cash By Market Cap	EUR 14.68
Net Cash Growth	-40.51%
Net Debt Equity	EUR -1.17
Tangible Book Value	EUR 3.4M
Tangible Book Value Per Share	EUR 0.12
WACC	11.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.68
Net Working Capital	EUR 30,533
Quick ratio	7.2
Working Capital	EUR 4.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-94.09%
1Y total return	-26.77%
200-day SMA	1.5
3Y total return	-93.3%
50-day SMA	1.34
50-day SMA vs 200-day SMA	50under200
5Y total return	-91.09%
All Time High	26
All Time High Change	-95.08%
All Time High Date	2016-01-13
All Time Low	0.41
All Time Low Change	212.2%
All Time Low Date	2024-04-17
ATR	0.03
Beta	1.38
Ch YTD	-11.72
High	1.3
High52	1.82
High52 Date	2025-10-10
High52ch	-29.67%
Low	1.28
Low52	1.24
Low52 Date	2026-04-24
Low52ch	3.23%
Ma50ch	-4.76%
Price vs 200-day SMA	-14.5%
RSI	42.24
RSI Monthly	34.53
RSI Weekly	34.02
Sharpe ratio	-0.88x
Sortino ratio	-1.12
Total Return	-3.53%
Tr YTD	-11.72
Tr1m	-2.66%
Tr1w	-2.66%
Tr3m	-10.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -7.8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,320,303%
Net Borrowing	-52,766.9
Shares Insiders	8.11%
Shares Institutions	10.19%
Shares Qo Q	6.57%
Shares Yo Y	3.53%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -8.2M
Average Volume	625.55x
Bv Per Share	0.14
CAPEX	EUR -5,234
Ch10y	-94.23
Ch1m	-2.66
Ch1w	-2.66
Ch1y	-26.77
Ch3m	-10.99
Ch3y	-93.3
Ch5y	-91.09
Ch6m	-21.95
Change	-1.54%
Change From Open	0.39
Close	1.3
Days Gap	-1.92
Depreciation Amortization	73,527.7
Dollar Volume	176.6
Earnings Date	2026-04-23
EBIT	EUR -7.8M
EBITDA	EUR -7.7M
EPS	EUR -0.29
F Score	2
FCF	EUR -7.4M
FCF EV Yield	-26.38x
Financing CF	4,113,238
Fiscal Year End	December
Founded	1,997
Investing CF	-5,234
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2025-12-31
Ma150	1.49
Ma150ch	-14.09%
Ma20	1.32
Ma20ch	-2.66%
Net CF	-3,267,909
Open	1.28
Position In Range	20
Ppne	104,668.8
Price Date	2026-05-08
Ptbv Ratio	9.55
Relative Volume	0.22x
Share Based Comp	779,029
Tr6m	-21.95%
Volume	138

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0R3M pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0R3M stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R3M?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.2%

Share of float held by funds and institutions

Insider ownership

+8.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.5%

Negative means the company is buying back shares.

Technical

LON/0R3M momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.2

Neutral momentum band

Price vs 200-day MA

-14.5%

50/200-day relationship not available

Beta (5Y)

1.38

More volatile than the market

Sharpe ratio

-0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R3M

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R3M stock rating?

lon/0R3M is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R3M analysis?

The full report lives at /stocks/lon/0R3M/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R3M?

The latest report frames lon/0R3M around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R3M page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.